This inventor holds 7 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Cipla Limited. Active years: 2011-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mulund, IN (2013)
- Maharashtra, IN (2011 - 2015)
- Mumbai, IN (2017 - 2022)
Company Filing History:
Years Active: 2011-2022
Title: Innovations of Ashwini Amol Sawant
Introduction
Ashwini Amol Sawant is a prominent inventor based in Maharashtra, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of seven patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Among her latest patents is the invention titled "Salts of antiviral phosphonate analogues and process for preparation thereof." This invention relates to specific acid salts of a complex chemical formula, along with processes for their preparation and pharmaceutical compositions that include these compounds. Additionally, she has developed an "Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine." This patent focuses on an efficient method for separating diastereomers and preparing related compounds.
Career Highlights
Ashwini Amol Sawant is currently employed at Cipla Limited, a leading pharmaceutical company. Her work at Cipla has allowed her to collaborate with other talented professionals in the field, enhancing her contributions to innovative pharmaceutical solutions.
Collaborations
Some of her notable coworkers include Dharmaraj Ramachandra Rao and Rajendra Narayanrao Kankan. Their collaboration has fostered a productive environment for research and development.
Conclusion
Ashwini Amol Sawant's innovative work in the pharmaceutical industry showcases her dedication to advancing medical science. Her patents reflect her commitment to developing effective treatments for diseases, making her a valuable contributor to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
